Invention Application
- Patent Title: OPTIMIZED ANTI-TL1A ANTIBODIES
-
Application No.: US16863971Application Date: 2020-04-30
-
Publication No.: US20200255510A1Publication Date: 2020-08-13
- Inventor: Jeffry D. Watkins , Cindy T. Dickerson , J. Monty Watkins
- Applicant: Prometheus Biosciences, Inc.
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61P1/04 ; C07K16/28
Abstract:
Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).
Public/Granted literature
- US11440954B2 Optimized anti-TL1A antibodies Public/Granted day:2022-09-13
Information query
